Regenxbio Inc
(NAS:RGNX)
$
11.6452
-0.4648 (-3.84%)
Market Cap: 575.54 Mil
Enterprise Value: 393.46 Mil
PE Ratio: 0
PB Ratio: 1.65
GF Score: 69/100 - Q2 2024 Regenxbio Inc Earnings Call TranscriptAug 01, 2024$13.31 (-6.60%)Earnings
- Q1 2024 Regenxbio Inc Earnings Call TranscriptMay 08, 2024$16.67 (-1.71%)Earnings
- Regenxbio Inc To Discuss Interim Clinical Data TranscriptMar 05, 2024
- Q4 2023 Regenxbio Inc Earnings Call TranscriptFeb 27, 2024$20.02 (+9.16%)Earnings
- Regenxbio Inc Interim Data Update TranscriptJan 16, 2024
- Regenxbio Inc at Stifel Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Regenxbio Inc Earnings Call TranscriptNov 08, 2023$16.41 (-0.18%)Earnings
- Regenxbio Inc Interim Data Update TranscriptNov 06, 2023
- Regenxbio Inc at World Muscle Society 2023 Data Update TranscriptOct 03, 2023
- Regenxbio Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Regenxbio Inc Earnings Call TranscriptAug 02, 2023$18.9 (-1.31%)Earnings
- Regenxbio Inc to Host Virtual Investor Day TranscriptJul 11, 2023
- Regenxbio Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Regenxbio Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Regenxbio Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 16, 2023
- Regenxbio Inc at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Q1 2023 Regenxbio Inc Earnings Call TranscriptMay 03, 2023$20.23 (+3.80%)Earnings
- Regenxbio Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) TranscriptApr 25, 2023
- Regenxbio Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 Regenxbio Inc Earnings Call TranscriptFeb 28, 2023$22.25 (+1.41%)Earnings
- Regenxbio Inc To Discuss Interim Data Update Call TranscriptFeb 11, 2023
- Regenxbio Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Regenxbio Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- Regenxbio Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Q3 2022 Regenxbio Inc Earnings Call TranscriptNov 03, 2022$21.05 (-13.16%)Earnings
- Regenxbio Inc To Discuss RGX-314 For The Treatment Of Wet AMD Call TranscriptOct 03, 2022
- Regenxbio Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Regenxbio Inc Earnings Call TranscriptAug 03, 2022$33.99 (+6.85%)Earnings
- Regenxbio Inc at UBS Global Healthcare Conference TranscriptMay 24, 2022
- Regenxbio Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Regenxbio Inc Earnings Call TranscriptMay 04, 2022$28.44 (+0.78%)Earnings
- Regenxbio Inc at Barclays Global Healthcare Conference TranscriptMar 17, 2022
- Q4 2021 Regenxbio Inc Earnings Call TranscriptMar 01, 2022$26.45 (+0.92%)Earnings
- Regenxbio Inc at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- Q3 2021 Regenxbio Inc Earnings Call TranscriptNov 02, 2021$36.59 (+1.19%)Earnings
- Regenxbio Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2021
- Regenxbio Inc KOL Conference Call to Discuss RGX-314 Data Presentations TranscriptOct 01, 2021
- Regenxbio Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Regenxbio Inc Call to Discuss Eye Care Collaboration with Abbvie Inc TranscriptSep 13, 2021
- Q2 2021 Regenxbio Inc Earnings Call TranscriptAug 09, 2021$32.5 (+3.80%)Earnings
- Regenxbio Inc at Bank of America NAPA Healthcare Conference (Virtual) TranscriptJun 16, 2021
- Regenxbio Inc at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Regenxbio Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q1 2021 Regenxbio Inc Earnings Call TranscriptMay 05, 2021$32.46 (-1.87%)Earnings
- Regenxbio Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 Regenxbio Inc Earnings Call TranscriptMar 01, 2021$42.51 (+3.91%)Earnings
- Regenxbio Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Regenxbio Inc at Barclays Virtual Gene Editing & Gene Therapy Summit TranscriptNov 16, 2020
- Regenxbio Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 12, 2020
- Q3 2020 Regenxbio Inc Earnings Call TranscriptNov 04, 2020$31.06 (+8.26%)Earnings
- Regenxbio Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Q2 2020 Regenxbio Inc Earnings Call TranscriptAug 06, 2020$34.3 (+0.32%)Earnings
- Regenxbio Inc RGX-314 Update Call TranscriptAug 04, 2020
- Q1 2020 Regenxbio Inc Earnings Call TranscriptMay 07, 2020$40.85 (-0.95%)Earnings
- Regenxbio Inc REGENXBIO RGX-314 Phase I/IIa Trial Update TranscriptApr 22, 2020
- Regenxbio Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Q4 2019 Regenxbio Inc Earnings Call TranscriptFeb 26, 2020$47.5 (-0.08%)Earnings
- Q3 2019 Regenxbio Inc Earnings Call TranscriptNov 05, 2019$37.62 (+1.40%)Earnings
- Regenxbio Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Regenxbio Inc, Uniqure NV at Citi Biotech Conference TranscriptSep 04, 2019
- Q2 2019 Regenxbio Inc Earnings Call TranscriptAug 07, 2019$40.54 (-1.36%)Earnings
- Regenxbio Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q1 2019 Regenxbio Inc Earnings Call TranscriptMay 07, 2019$49.88 (-4.66%)Earnings
- Regenxbio Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Q4 2018 Regenxbio Inc Earnings Call TranscriptFeb 27, 2019$53.24 (+0.64%)Earnings
- Regenxbio Inc Analyst and Investor Event TranscriptFeb 21, 2019
Regenxbio Inc at UBS Global Healthcare Virtual Conference Transcript
May 25, 2021 / 03:00PM GMT
Release Date Price:
$33.54
(-2.27%)
Esther P. Rajavelu
UBS Investment Bank, Research Division - Analyst & Executive Director
Good morning, everyone, and thank you for joining us at the UBS Virtual Healthcare Conference Day 2.
I'm excited to have the REGENX management team here with us for a fireside chat, and we're joined by REGENX Chief Medical Officer, Steve Pakola; and Chief Scientific Officer, Olivier Danos.
Gentlemen, welcome, and thank you for making time for us.
Stephen Pakola
REGENXBIO Inc. - Senior VP & Chief Medical Officer
Good morning Esther. Thanks for the invitation. We're glad to be with -- here with you.
Olivier Danos
REGENXBIO Inc. - Senior VP & Chief Scientific Officer
Good morning.
Esther P. Rajavelu
UBS Investment Bank, Research Division - Analyst & Executive Director
And I apologize for not being on camera. We've had some technical difficulty. But perhaps, Steve, maybe you can start us off with what's on tap for the rest of the year and give us
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)